India Cancer Drug Price Cap 2026: Hospital Profit Risk
India cancer drug price cap 2026 could cut some hospitals’ EBITDA by 1.5% to 3%, one analysis estimates. What is confirmed and what is a projection.
India cancer drug price cap 2026 could cut some hospitals’ EBITDA by 1.5% to 3%, one analysis estimates. What is confirmed and what is a projection.